Microfluidic Devices for Drug Delivery Systems and Drug Screening

• Main Authors: Samar Damiati, Uday B. Kompella, Safa A. Damiati, Rimantas Kodzius
• Format: Article
• Language: English
• Published: MDPI AG 2018-02-01
• Series: Genes
• Subjects: drug and gene delivery systems; in vitro drug screening; cell-on-a-chip; organ-on-a-chip; human-on-a-chip
• Online Access: http://www.mdpi.com/2073-4425/9/2/103

Microfluidic devices present unique advantages for the development of efficient drug carrier particles, cell-free protein synthesis systems, and rapid techniques for direct drug screening. Compared to bulk methods, by efficiently controlling the geometries of the fabricated chip and the flow rates of multiphase fluids, microfluidic technology enables the generation of highly stable, uniform, monodispersed particles with higher encapsulation efficiency. Since the existing preclinical models are inefficient drug screens for predicting clinical outcomes, microfluidic platforms might offer a more rapid and cost-effective alternative. Compared to 2D cell culture systems and in vivo animal models, microfluidic 3D platforms mimic the in vivo cell systems in a simple, inexpensive manner, which allows high throughput and multiplexed drug screening at the cell, organ, and whole-body levels. In this review, the generation of appropriate drug or gene carriers including different particle types using different configurations of microfluidic devices is highlighted. Additionally, this paper discusses the emergence of fabricated microfluidic cell-free protein synthesis systems for potential use at point of care as well as cell-, organ-, and human-on-a-chip models as smart, sensitive, and reproducible platforms, allowing the investigation of the effects of drugs under conditions imitating the biological system.